What is Utah Medical Products's market cap?

Utah Medical Products (UTMD) has a market capitalization of $225.9M and trades on NASDAQ.

What is Utah Medical Products's revenue and profitability?

Utah Medical Products generated $36.1M in trailing twelve-month revenue with net income of $10.5M, representing a net margin of 29.0%. Gross margin stands at 57.9%. These figures are based on the Q2 2026 filing.

Who are Utah Medical Products's competitors?

Utah Medical Products's key competitors include CooperSurgical Inc., Teleflex Incorporated, C.R. Bard, Inc., and others. These companies compete in similar markets and product categories.

Who does Utah Medical Products partner with?

Utah Medical Products's notable partners include CooperSurgical Inc., Lubrizol Advanced Materials, Inc..

What subsidiaries does Utah Medical Products have?

Utah Medical Products's subsidiaries include Utah Medical Products Ltd, Femcare Holdings Ltd, Columbia Medical, Inc., and others.

Where is Utah Medical Products headquartered?

Utah Medical Products is headquartered in United States of America and employs approximately 190 people. It has been publicly traded since 1982.

Utah Medical Products

UTMD

Utah Medical Products Inc develops, manufactures, and markets specialized medical devices designed for critical care, surgical, and biopharmaceutical applications.

Market cap

$225.94M+24.6%

Revenue$36.1M-7.0%

Net income$10.5M-16.5%

EPS (diluted)$3.28-12.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

July 23, 2026

Revenue$8.5M EPS$0.84

Read the full report

Next report

Oct 22, 2026 (in 3 months)

Financials

Q2 2026

Income statement

See full

Revenue$8.5M-14.3%

Gross profit$4.8M-15.0%

Operating income$2.6M-17.1%

Net income$2.7M-11.9%

EPS (diluted)$0.84-10.2%

Balance sheet

See full

Cash & equivalents$87.5M+6.5%

Total equity$122.0M+3.8%

Total assets$124.6M+3.1%

Valuation & ratios

Valuation

See full

Market cap$225.94M+24.6%

P/E21.6×+7.1×

P/S6.3×+1.6×

Profitability

See full

Gross margin57.9%+0.6pp

Operating margin28.4%-4.1pp

Net margin29%-3.3pp

Returns & leverage

See full

Return on equity8.8%-1.6pp

Current ratio48.6×+6.7×

Competitors

By market cap

Becton, Dickinson and Company$45.8B-12.3%

Medline, Inc. $34.3B—

The Cooper Companies, Inc.$14.1B-4.4%

TFX

Teleflex$5.9B+16.4%

Merit Medical Systems$4.7B-4.6%

Pediatrix Medical Group$2.2B+103%

IAR

Integra LifeSciences$1.5B+53.8%

Utah Medical Products$225.9M+24.5%

By revenue growth

TFX

Teleflex+25.0%

Merit Medical Systems+11.1%

Medline, Inc. +9.8%

Becton, Dickinson and Company+6.4%

The Cooper Companies, Inc.+6.1%

IAR

Integra LifeSciences+1.6%

Pediatrix Medical Group-2.3%

Utah Medical Products-7.0%

By net margin

Utah Medical Products29.04%-3.3pp

Merit Medical Systems9.03%+0.2pp

Pediatrix Medical Group9.02%+14.5pp

The Cooper Companies, Inc.5.57%-4.8pp

Becton, Dickinson and Company5.33%-2.1pp

Medline, Inc. 4.62%-0.7pp

IAR

Integra LifeSciences-0.44%+32.4pp

TFX

Teleflex-47.43%-56.2pp

Profile

Utah Medical Products Inc develops, manufactures, and markets specialized medical devices designed for critical care, surgical, and biopharmaceutical applications. The company focuses on high-quality, cost-effective solutions that improve patient safety and clinical outcomes in niche medical fields. Its value proposition centers on integrating engineering disciplines to create differentiated products that reduce the total cost of care and minimize procedural complications.

Competitive position

The company maintains a strong competitive position through established brand recognition and specialized clinical utility in niche markets like neonatal care and permanent contraception. It competes by offering differentiated safety features rather than competing solely on unit price.

GeographiesUnited States, United Kingdom, Ireland, Australia, Canada, France, New Zealand

Customer segmentsHospitals, Specialty Clinics, Biopharmaceutical Manufacturers

Business modelManufacturing, Direct-to-Consumer Sales, B2B, OEM

SuppliersSilicone and plastic resin suppliers, Electronic component manufacturers, Tungsten and titanium suppliers, Sterilization service providers

CustomersHospital Group Purchasing Organizations (GPOs), Medical/Surgical Distributors, Biopharmaceutical manufacturing firms, Independent medical product distributors

CountryUnited States of America

Listed1982

Employees190.0

CEOKevin L. Cornwell

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteutahmed.com

FilingsSEC EDGAR

Ask your AI about Utah Medical Products.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's market cap?: Utah Medical Products (UTMD) has a market capitalization of $225.9M and trades on NASDAQ.
What is Utah Medical Products's revenue and profitability?: Utah Medical Products generated $36.1M in trailing twelve-month revenue with net income of $10.5M, representing a net margin of 29.0%. Gross margin stands at 57.9%. These figures are based on the Q2 2026 filing.
Who are Utah Medical Products's competitors?: Utah Medical Products's key competitors include CooperSurgical Inc., Teleflex Incorporated, C.R. Bard, Inc., and others. These companies compete in similar markets and product categories.
Who does Utah Medical Products partner with?: Utah Medical Products's notable partners include CooperSurgical Inc., Lubrizol Advanced Materials, Inc..
What subsidiaries does Utah Medical Products have?: Utah Medical Products's subsidiaries include Utah Medical Products Ltd, Femcare Holdings Ltd, Columbia Medical, Inc., and others.
Where is Utah Medical Products headquartered?: Utah Medical Products is headquartered in United States of America and employs approximately 190 people. It has been publicly traded since 1982.